Last reviewed · How we verify
NCT04266262
High-Intensity Training for Men With Prostate Cancer on Active Surveillance: A Feasibility Study
NA trial testing High-intensity interval training (HIIT) in Prostate Cancer in 25 participants. Terminated before completion.
18 March 2020
Quick facts
| Lead sponsor | University of Toronto |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 25 |
| Start date | 9 July 2018 |
| Primary completion | 18 March 2020 |
| Estimated completion | 20 March 2020 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- High-intensity interval training (HIIT)
- High-Intensity resistance training (HIRT)
Conditions studied
- Prostate Cancer — all drugs for Prostate Cancer →
Sponsor
University of Toronto
Who can join
Adults 18 to 75, male only, with Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomized study aiming to assess the feasibility of a phase II randomized controlled trial of different high-intensity training interventions and usual care (UC) in men with prostate cancer (PCa) undergoing active surveillance (AS).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
High-intensity interval training or resistance training versus usual care in men with prostate cancer on active surveillance: a 3-arm feasibility randomized controlled trial.
Papadopoulos E, Gillen J, Moore D, Au D, et al · · 2021 · cited 18× · PMID 34380000 · DOI 10.1139/apnm-2021-0365
Verify or expand the search:
- PubMed search for NCT04266262
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High-intensity interval training (HIIT)
Trials testing the same drug.
- NCT05259449 — Efficacy of Educational Nutrition and Exercise on the Regulation of Appetite Through Exosomes in Type 2 Diabetics · NA · active not recruiting
- NCT05085860 — Acute Responses to Exercise in Females and Males With Symptomatic Atrial Fibrillation · NA · recruiting
- NCT04450134 — Histamine H1/H2 Receptors and Training Adaptations · NA · completed
- NCT04065815 — Protein-rich Nutritional Therapy Combined With Time-efficient Exercise in Cancer Therapy · NA · unknown
- NCT05487716 — HIIT Effects on Long-term Survival in Heart Failure Patients · completed
Other recruiting trials for Prostate Cancer
Currently open trials in the same condition.
- NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
- NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting
- NCT07234981 — PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer · Phase 2 · recruiting
- NCT07027124 — Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Ris · Phase 2 · recruiting
- NCT07426094 — PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate · Phase 2, PHASE3 · recruiting
Other University of Toronto trials
Trials by the same sponsor.
- NCT07184255 — Animated Video Education for Retinal Surgery · NA · not yet recruiting
- NCT07259434 — Time Restricted Eating in Survivors Trial 2.0 · NA · not yet recruiting
- NCT07486050 — The Impact of Social Worker Referrals on Diabetes and Loneliness · NA · active not recruiting
- NCT07268729 — Investigation of Pathogenic Gut Microbiota Patterns in Anxiety, Depression and Panic Disorders · not yet recruiting
- NCT07317921 — Validating IAAO for Muscle Outcomes · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04266262 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Toronto
- Last refreshed: 4 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04266262.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing